Fact Sheet: President Donald J. Trump is Increasing Medical Marijuana and Cannabidiol Research
Fact sheetRegulation easedPublished 25/12/18Open the original
Summary
President Trump directs the Attorney General to expedite rescheduling marijuana to Schedule III of the Controlled Substances Act and HHS to develop research methods to improve access to hemp-derived cannabinoid products; the fact sheet notes 40 states plus D.C. have medical marijuana programs.
By industry
- Healthcare & Drug Pricing1 trading day−0.5%p15 stocks5 trading days−0.8%p15 stocks20 trading days−0.0%p15 stocks
“expedite completion of the process of rescheduling marijuana to Schedule III of the Controlled Substance Act (CSA)”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/12/17 | 0.0% | 0.0% |
| 25/12/18 | −0.1% | +0.5% |
| 25/12/19 | +0.5% | +1.2% |
| 25/12/22 | +1.2% | +1.8% |
| 25/12/23 | +1.2% | +2.2% |
| 25/12/24 | +1.8% | +2.6% |
| 25/12/26 | +2.0% | +2.6% |
| 25/12/29 | +1.8% | +2.2% |
| 25/12/30 | +1.7% | +2.1% |
| 25/12/31 | +1.2% | +1.4% |
| 26/01/02 | +1.7% | +1.6% |
| 26/01/05 | +1.3% | +2.2% |
| 26/01/06 | +2.8% | +2.9% |
| 26/01/07 | +3.5% | +2.6% |
| 26/01/08 | +2.7% | +2.6% |
| 26/01/09 | +2.1% | +3.2% |
| 26/01/12 | +2.4% | +3.3% |
| 26/01/13 | +2.4% | +3.1% |
| 26/01/14 | +3.4% | +2.5% |
| 26/01/15 | +3.7% | +2.9% |
| 26/01/16 | +2.8% | +2.8% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$128.2M
120,016 sh
$128.2M
Filed 25/11/25
Traded 25/11/24
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$101.4M
96,516 sh
$101.4M
Filed 25/11/20
Traded 25/11/19
- John G. Morikis
BuyJohnson & Johnson
BuyJohnson & Johnson
JNJ
$257.7K
1,250 sh
$257.7K
Filed 25/12/01
Traded 25/11/26
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$45.2M
40,956 sh
$45.2M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$38M
34,434 sh
$38M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.2M
28,768 sh
$30.2M
Filed 25/11/20
Traded 25/11/19
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.9M
24,362 sh
$26.9M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$25.3M
23,916 sh
$25.3M
Filed 25/11/24
Traded 25/11/21
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$23.2M
21,042 sh
$23.2M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.8M
20,668 sh
$22.8M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.5M
20,447 sh
$22.5M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.2M
21,107 sh
$22.2M
Filed 25/11/20
Traded 25/11/19
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$19.9M
18,254 sh
$19.9M
Filed 25/11/26
Traded 25/11/25
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$18.4M
16,650 sh
$18.4M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$17.7M
16,845 sh
$17.7M
Filed 25/11/21
Traded 25/11/20
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$16.4M
14,937 sh
$16.4M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$15.2M
13,701 sh
$15.2M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$15.1M
14,105 sh
$15.1M
Filed 25/11/25
Traded 25/11/24
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$14.7M
13,247 sh
$14.7M
Filed 01/08
Traded 01/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$14.6M
13,820 sh
$14.6M
Filed 25/11/20
Traded 25/11/19